Hydroxyglutaric aciduria and malignant brain tumor: a case report and literature review - PubMed (original) (raw)

Review

Hydroxyglutaric aciduria and malignant brain tumor: a case report and literature review

Mahdi Aghili et al. J Neurooncol. 2009 Jan.

Abstract

L -2-Hydroxyglutaric aciduria (L -2-OHGA) is a rare autosomal recessive inherited encephalopathy. This inborn error, characterized by psychomotor retardation, progressive ataxia and typical magnetic resonance imaging findings, presents in early infancy. To make a definitive diagnosis, an anomalous accumulation of L -2-hydroxyglutaric acid must be detected in body fluids. Here, we present a 17-year-old boy with L: -2-OHGA who developed an anaplastic ependymoma during the course of this disease. We also present a literature review including seven other patients who developed malignant brain tumors during the course of L -2-OHGA. This correlation may indicate a possible increased risk of brain tumors among patients with L -2-hydroxyglutaric aciduria.

PubMed Disclaimer

Similar articles

• Medulloblastoma in a child with the metabolic disease L-2-hydroxyglutaric aciduria.
  Ozişik PA, Akalan N, Palaoğlu S, Topçu M. Ozişik PA, et al. Pediatr Neurosurg. 2002 Jul;37(1):22-6. doi: 10.1159/000065097. Pediatr Neurosurg. 2002. PMID: 12138215
• Osteoma of the calvaria in L-2-hydroxyglutaric aciduria.
  Larnaout A, Amouri R, Neji S, Zouari M, Kaabachi N, Hentati F. Larnaout A, et al. J Inherit Metab Dis. 2007 Nov;30(6):980. doi: 10.1007/s10545-007-0576-0. Epub 2007 Oct 5. J Inherit Metab Dis. 2007. PMID: 17917788
• Combined D-2- and L-2-hydroxyglutaric aciduria with neonatal onset encephalopathy: a third biochemical variant of 2-hydroxyglutaric aciduria?
  Muntau AC, Röschinger W, Merkenschlager A, van der Knaap MS, Jakobs C, Duran M, Hoffmann GF, Roscher AA. Muntau AC, et al. Neuropediatrics. 2000 Jun;31(3):137-40. doi: 10.1055/s-2000-7497. Neuropediatrics. 2000. PMID: 10963100
• L-2-hydroxyglutaric aciduria and brain malignant tumors: a predisposing condition?
  Moroni I, Bugiani M, D'Incerti L, Maccagnano C, Rimoldi M, Bissola L, Pollo B, Finocchiaro G, Uziel G. Moroni I, et al. Neurology. 2004 May 25;62(10):1882-4. doi: 10.1212/01.wnl.0000125335.21381.87. Neurology. 2004. PMID: 15159502 Review.
• A novel compound heterozygous mutation of the L2HGDH gene in a Chinese boy with L-2-hydroxyglutaric aciduria: case report and literature review.
  Zhang Y, Wang C, Yang K, Wang S, Tian G, Chen Y. Zhang Y, et al. Neurol Sci. 2018 Oct;39(10):1697-1703. doi: 10.1007/s10072-018-3483-2. Epub 2018 Jul 6. Neurol Sci. 2018. PMID: 29980873 Review.

Cited by

• IDH1 mutations inhibit multiple α-ketoglutarate-dependent dioxygenase activities in astroglioma.
  Liu Y, Jiang W, Liu J, Zhao S, Xiong J, Mao Y, Wang Y. Liu Y, et al. J Neurooncol. 2012 Sep;109(2):253-60. doi: 10.1007/s11060-012-0914-4. Epub 2012 Jul 8. J Neurooncol. 2012. PMID: 22772731
• Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy.
  Pope WB, Prins RM, Albert Thomas M, Nagarajan R, Yen KE, Bittinger MA, Salamon N, Chou AP, Yong WH, Soto H, Wilson N, Driggers E, Jang HG, Su SM, Schenkein DP, Lai A, Cloughesy TF, Kornblum HI, Wu H, Fantin VR, Liau LM. Pope WB, et al. J Neurooncol. 2012 Mar;107(1):197-205. doi: 10.1007/s11060-011-0737-8. Epub 2011 Oct 21. J Neurooncol. 2012. PMID: 22015945 Free PMC article.
• Differential activity of NADPH-producing dehydrogenases renders rodents unsuitable models to study IDH1R132 mutation effects in human glioblastoma.
  Atai NA, Renkema-Mills NA, Bosman J, Schmidt N, Rijkeboer D, Tigchelaar W, Bosch KS, Troost D, Jonker A, Bleeker FE, Miletic H, Bjerkvig R, De Witt Hamer PC, Van Noorden CJ. Atai NA, et al. J Histochem Cytochem. 2011 May;59(5):489-503. doi: 10.1369/0022155411400606. Epub 2011 Feb 10. J Histochem Cytochem. 2011. PMID: 21527585 Free PMC article.
• Mechanisms underlying the biological changes induced by isocitrate dehydrogenase-1 mutation in glioma cells.
  Wang JB, Dong DF, Gao K, Wang MD. Wang JB, et al. Oncol Lett. 2014 Mar;7(3):651-657. doi: 10.3892/ol.2014.1806. Epub 2014 Jan 16. Oncol Lett. 2014. PMID: 24520288 Free PMC article.
• Altered metabolite levels in cancer: implications for tumour biology and cancer therapy.
  Sullivan LB, Gui DY, Vander Heiden MG. Sullivan LB, et al. Nat Rev Cancer. 2016 Nov;16(11):680-693. doi: 10.1038/nrc.2016.85. Epub 2016 Sep 23. Nat Rev Cancer. 2016. PMID: 27658530 Review.

References

1. 1. J Neurobiol. 2003 Feb 15;54(3):457-72 - PubMed
2. 1. Neurol Sci. 2000 Apr;21(2):103-8 - PubMed
3. 1. J Inherit Metab Dis. 1996;19(3):335-43 - PubMed
4. 1. Neurol Med Chir (Tokyo). 2004 Mar;44(3):124-8 - PubMed
5. 1. Ann Neurol. 1992 Jul;32(1):66-71 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Springer

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Consumer Health Information
  • MedlinePlus Health Information

• Molecular Biology Databases

  • The Weizmann Institute of Science GeneCards and MalaCards databases